Comments on: What Is Erythritol: Friend or Foe? https://composemd.com/2023/03/13/what-is-erythritol-friend-or-foe/?utm_source=rss&utm_medium=rss&utm_campaign=what-is-erythritol-friend-or-foe Making the world a little bit smarter. Mon, 20 Mar 2023 11:36:20 +0000 hourly 1 https://wordpress.org/?v=6.9.4 By: Amol Shrikhande https://composemd.com/2023/03/13/what-is-erythritol-friend-or-foe/#comment-1015 Mon, 20 Mar 2023 11:36:20 +0000 https://composemd.com/?p=5030#comment-1015 In reply to rao vempaty.

Good question. Most of those studied were over age 60 and already had cardiovascular disease or were at higher risk for cardiovascular disease due to diabetes, high blood pressure, etc. So the results can’t be extrapolated to the general population. And for those in the high-risk population, what to do at this point is unclear—moderation is always a reasonable first step.

]]> By: Amol Shrikhande https://composemd.com/2023/03/13/what-is-erythritol-friend-or-foe/#comment-1012 Mon, 20 Mar 2023 11:27:08 +0000 https://composemd.com/?p=5030#comment-1012 In reply to Vinay V Shrikhande.

Thank you. It will be interesting to see what future studies show.

]]> By: rao vempaty https://composemd.com/2023/03/13/what-is-erythritol-friend-or-foe/#comment-1009 Sat, 18 Mar 2023 23:22:20 +0000 https://composemd.com/?p=5030#comment-1009 study is done in high risk population? does it mean anything?

]]> By: Vinay V Shrikhande https://composemd.com/2023/03/13/what-is-erythritol-friend-or-foe/#comment-1008 Sat, 18 Mar 2023 13:14:13 +0000 https://composemd.com/?p=5030#comment-1008 Excellent article explaining the latest news.

]]>